Found: 5
Select item for more details and to access through your institution.
PTPRT loss enhances anti–PD-1 therapy efficacy by regulation of STING pathway in non–small cell lung cancer.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 763, p. 1, doi. 10.1126/scitranslmed.adl3598
- By:
- Publication type:
- Article
SETD2 epidermal deficiency promotes cutaneous wound healing via activation of AKT/mTOR Signalling.
- Published in:
- Cell Proliferation, 2021, v. 54, n. 6, p. 1, doi. 10.1111/cpr.13045
- By:
- Publication type:
- Article
Loss of SETD2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/ERK signalling pathway.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 11, p. 1, doi. 10.1002/ctm2.1475
- By:
- Publication type:
- Article
SETD2 deficiency promotes renal fibrosis through the TGF‐β/Smad signalling pathway in the absence of VHL.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 11, p. 1, doi. 10.1002/ctm2.1468
- By:
- Publication type:
- Article
Stomach-specific c-Myc overexpression drives gastric adenoma in mice through AKT/mammalian target of rapamycin signaling.
- Published in:
- Bosnian Journal of Basic Medical Sciences, 2021, v. 21, n. 4, p. 434, doi. 10.17305/bjbms.2020.4978
- By:
- Publication type:
- Article